Zydus Lifesciences Gets US FDA Final Nod for Eluxadoline Tablets

Zydus Lifesciences has received final approval from the US Food and Drug Administration (USFDA) to manufacture Eluxadoline Tablets, 75 mg and 100 mg. Eluxadoline is a mu-opioid receptor agonist, indicated in adults for the treatment of irritable bowel syndrome with diarrhoea.

https://www.cnbctv18.com/market/zydus-life-share-price-receives-final-approval-from-usfda-for-eluxadoline-tablets-19573999.htm